Frequency of insulin-dependent diabetes mellitus in Turkish adult-onset diabetic population

Krolewski AS, Warram JH, Rand LI, Kahn CR, Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317:1390–1398, 1987

Karjalainen J, Salmela P, Ilonen J, Surcel HM, Knip M. A comparison of childhood and adult type I diabetes mellitus. N Engl J Med 320:881–886, 1989

Libman I, Songer T, LaPorte R, How many people in the U.S. have IDDM? Diabetes Care 16:841–842, 1993

Melton LJ, Palumbo PJ, Chu CP, Incidence of diabetes mellitus by clinical type. Diabetes Care 6:75–81, 1983

Melton LJ, Ochi JW, Palumbo PJ, Chu CP, Sources of disparity in the spectrum of diabetes mellitus at incidence and prevalence. Diabetes Care 6:427–431, 1983

Laakso M, Pyorola K, Age of onset and type of diabetes. Diabetes Care 8:114–117, 1985

Harris MJ, Robbins DC, Prevalence of adult-onset IDDM in the U.S. population. Diabetes Care 17:1337–1340, 1994

Faber OK, Binder C, C-peptide response to glucagon: a test for the residual beta cell function in diabetes mellitus. Diabetes 26:605–610, 1977

Kumar MS, Schumacher OP, Deodhar SD, Measurement of serum C-peptide immunoreactivity by radioimmunoassay in insulin-dependent diabetics. Am J Clin Pathol 74:78–83, 1980

Boitard C, Bonifacio E, Bottazzo GF, Gleichman H, Molenaar J, Immunology and diabetes workshop: report on the third international (stage 3) workshop on standardization of cytoplasmic islet cell antibodies. Diabetologia 31:451–452, 1988

Hagopian W, Lernmark A, Autoimmune diabetes mellitus. In: Rose NE, Mackay IR (eds) The autoimmune diseases II. Academic Press, New York, pp 235–278, 1992

Madsbad S, Classification of diabetes in older adults. Diabetes Care 13 (Suppl 2):93–96, 1990

Wilson BM, Van der Minne P, Deverill J, Insulin dependence: problems with the classification of 100 consecutive patients. Diabetic Med 2:167–172, 1985

Groop LC, Bottazzo GF, Doniach D, Islet cell aantibodies indentify latent type I diabetes in patients aged 35–75 years at diagnosis. Diabetes 35:237–241, 1986

Arslanian SA, Becker DJ, Rabin B, Correlates of insulin antibodies in newly diagnosed children with insulindependent diabetes before insulin therapy. Diabetes 34:926–930, 1985

Karjalainen J, Knip M, Mustonen A, Akerblom HK, Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM. Diabetes 35:620–622, 1986

Irvine WJ, McCallum CJ, Gray RS, Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Diabetes 26:138–147, 1977

Del Prete GF, Betterle C, Padovan D, Erle G, Toffolo A, Bersahi G, Incidence and significance of islet-cell autoantibodies in different types of diabetes mellitus. Diabetes 26:909–915, 1977

Landin-Olsson M, Nilsson KO,Lernmark A, Sundkvist G, Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 33:561–568, 1990

Groop LC, Miettinen A, Groop P-H, Meri S, Koskimies S, Bottazzo GF, Organ-specific autoimmunity and HLA-DR antigens as markers for B-cell destruction in patients with type II diabetes. Diabetes 37:99–103, 1988

Madsbad S, Krarup T, McNair P, Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 210: 153–156, 1981